These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37848604)

  • 1. Alloimmune hemolytic disease of the fetus and newborn: genetics, structure, and function of the commonly involved erythrocyte antigens.
    Christensen RD; Bahr TM; Ilstrup SJ; Dizon-Townson DS
    J Perinatol; 2023 Dec; 43(12):1459-1467. PubMed ID: 37848604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
    Roubalová L; Lubušký M
    Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red Blood Cell Alloimmunization in the Pregnant Patient.
    Webb J; Delaney M
    Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
    Delaney M; Matthews DC
    Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective Analysis of Irregular Antibodies Causing Hemolytic Disease of the Fetus and Newborn in Jiangxi Province].
    Liu X; LE F; Wang LH; Shu J; Xu XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):215-220. PubMed ID: 36765502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report.
    Sahoo D; Anuragaa S; Abhishekh B
    Immunohematology; 2023 Apr; 39(1):11-14. PubMed ID: 37017597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of severe hemolytic disease of newborn due to alloimmunization in primigravida.
    Pandey P; Kumari S; Mandal S; Sawhney A; Jain R
    Transfus Clin Biol; 2023 Feb; 30(1):5-7. PubMed ID: 35944885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incompatible red blood cell transfusion for hemolytic disease of the fetus and newborn secondary to anti-U: A case report.
    Badawi MA; Al-Wassia H
    Transfusion; 2023 Feb; 63 Suppl 1():S28-S32. PubMed ID: 36748668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
    Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
    Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal hemolytic disease of the fetus and newborn caused by anti-Jr
    Kim MS; Kim JS; Park H; Chung Y; Kim H; Ko DH; Hwang SH; Won HS; Oh HB
    Transfus Apher Sci; 2020 Feb; 59(1):102605. PubMed ID: 31324575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of Hemolytic Disease of the Fetus and Newborn Caused by Anti-s Antibody in a Chinese Patient.
    Liyan Y; Yongmei J; Jing F
    Clin Lab; 2023 Apr; 69(4):. PubMed ID: 37057931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
    Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
    Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic Disease of the Fetus and Newborn Caused by Maternal Autoantibody with Mimicking Anti-E Specificity.
    Chen X; Feng J; Jiang Y
    Lab Med; 2021 Jul; 52(4):399-402. PubMed ID: 33219819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
    De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
    Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic disease of the fetus and newborn caused by irregular antibody: A mortality case report and case series during the past 15 years in NCKUH.
    Chuang MT; Chang CH
    Taiwan J Obstet Gynecol; 2022 Sep; 61(5):896-899. PubMed ID: 36088064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jk3 alloantibodies during pregnancy-blood bank management and hemolytic disease of the fetus and newborn risk.
    Lawicki S; Coberly EA; Lee LA; Johnson M; Eichbaum Q
    Transfusion; 2018 May; 58(5):1157-1162. PubMed ID: 29479723
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.